ADVI Health’s senior director, emerging therapies, Alicia Silver, recently sat down with Empowered Patient Podcast to discuss the current landscape of cell and gene therapy, the FDA’s removal of Risk Evaluation Mitigation Strategies (REMS), inpatient vs. outpatient CAR-T therapy, and more.

Listen to the episode and access the transcript of Alicia’s insights on the Empowered Patient Podcast.